Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Grayson

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Translational Psychiatry|May 21, 2021
Transcriptomics identifies STAT3 as a key regulator of hippocampal gene expression and anhedonia during withdrawal from chronic alcohol exposureWei-Yang Chen, Hu Chen, Kana Hamada, et al.
Archives of General Psychiatry|November 14, 2000
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain studyA Guidotti, J Auta, J M Davis, et al.
Cancer Discovery|May 31, 2014
NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanismChristopher A French, Shaila Rahman, Erica M Walsh, et al.
Oncogene|April 23, 2013
MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinomaAdlai R Grayson, Erica M Walsh, Michael J Cameron, et al.
Biomarkers in Neuropsychiatry|August 9, 2021
Gene Expression Of Methylation Cycle And Related Genes In Lymphocytes And Brain Of Patients With Schizophrenia And Non-Psychotic ControlsHenry Sershen, Alessandro Guidotti, James Auta, et al.
Molecular Cancer Therapeutics|May 7, 2020
Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid ReceptorRemi Adelaiye-Ogala, Berkley E Gryder, Yen Thi Minh Nguyen, et al.
Nature Reviews. Drug Discovery|March 5, 2016
Altering the course of schizophrenia: progress and perspectivesMark J Millan, Annie Andrieux, George Bartzokis, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Translational Psychiatry|May 21, 2021
Transcriptomics identifies STAT3 as a key regulator of hippocampal gene expression and anhedonia during withdrawal from chronic alcohol exposureWei-Yang Chen, Hu Chen, Kana Hamada, et al.
Archives of General Psychiatry|November 14, 2000
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain studyA Guidotti, J Auta, J M Davis, et al.
Cancer Discovery|May 31, 2014
NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanismChristopher A French, Shaila Rahman, Erica M Walsh, et al.
Oncogene|April 23, 2013
MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinomaAdlai R Grayson, Erica M Walsh, Michael J Cameron, et al.
Biomarkers in Neuropsychiatry|August 9, 2021
Gene Expression Of Methylation Cycle And Related Genes In Lymphocytes And Brain Of Patients With Schizophrenia And Non-Psychotic ControlsHenry Sershen, Alessandro Guidotti, James Auta, et al.
Molecular Cancer Therapeutics|May 7, 2020
Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid ReceptorRemi Adelaiye-Ogala, Berkley E Gryder, Yen Thi Minh Nguyen, et al.
Nature Reviews. Drug Discovery|March 5, 2016
Altering the course of schizophrenia: progress and perspectivesMark J Millan, Annie Andrieux, George Bartzokis, et al.
Pageof 18